ELSA AI · Clinical AI Governance
Where AI exposure hides in a private clinic
Ambient scribes, ChatGPT, Microsoft Copilot, transcription and admin tools are already in use across most clinics, often before any governance position is documented. This map shows the exposure themes a board should understand, and the controls that reduce each one.
This map is illustrative; your clinic’s actual position comes from the Diagnostic.
Three forces create AI exposure
External threat actors
Targeting patient data, accounts and the vendor supply chain behind AI tools.
Well-meaning insiders
Clinicians and staff using AI to save time, often working around gaps that governance has not yet closed.
The technology itself
AI’s own failure modes: confident but incorrect output (hallucination) and uneven performance across populations (bias).
Exposure themes
Three themes by what is at stake. Open a theme to see how the exposure typically arises and what it means. Priority levels show the general pattern across clinics, not a rating of any single practice.
- How it arises
- Staff use unapproved consumer AI tools to draft letters or summarise histories.
- What happens
- Identifiable health data is entered into public tools and can be retained to train future model versions.
- What it means
- A confidentiality and data-protection exposure that sits outside the clinic’s assurance position and warrants DPO and legal review.
- How it arises
- Ambient scribe data is processed outside the UK without a documented data processing agreement or transfer mechanism.
- What happens
- Data is exposed where encryption and access controls are not evidenced.
- What it means
- A vendor jurisdiction and international transfer point requiring DPO and legal review and vendor confirmation.
- How it arises
- Ambient voice tools capture consultation dialogue without applying data minimisation.
- What happens
- Raw audio and verbatim transcripts are kept without documented justification or deletion.
- What it means
- A retention and minimisation review point. A data protection impact assessment is likely indicated.
How clinics reduce this exposure
The guardrails that close most of the map. Each shows the practical trade-off across four axes. For risk reduction and readiness, more bars is stronger; for cost and complexity, fewer bars is lighter.
Governance
Impact assessment and clinical safety case
Run a live data protection impact assessment and a local clinical safety case before deployment, and name a trained Clinical Safety Officer.
Risk reduction
Cost
Complexity
Readiness
Identity & dataQUICK WIN
Close down shadow AI
Block consumer AI tools on clinic devices and offer a sanctioned, private alternative so staff have a safe route.
Risk reduction
Cost
Complexity
Readiness
Clinical practice
Review before it reaches the record
Require every AI output to be actively reviewed and corrected by the clinician before it enters the patient record, with an auditable marker for AI-assisted entries.
Risk reduction
Cost
Complexity
Readiness
Privacy by design
Delete what is no longer needed
Set tools to delete raw audio and verbatim transcripts once the verified summary exists.
Risk reduction
Cost
Complexity
Readiness
ProcurementQUICK WIN
Match the tool to its approved use
Check each tool against its registered intended purpose and rule out using an administrative tool for clinical decisions.
Risk reduction
Cost
Complexity
Readiness
See where your clinic stands
This map shows common themes. The Clinical AI Exposure Diagnostic™ maps your declared and shadow AI use, your evidence gaps and a 30-day priority action plan, as a fixed-fee review delivered in four working days.
What ELSA AI does not do
- Provide legal advice or determine legal compliance
- Give CQC or ICO approval
- Determine insurer coverage or MDO indemnity
- Sign off clinical safety cases or author DCB0160
- Guarantee compliance or a CQC outcome
This resource is an illustrative governance map of common AI exposure themes in private healthcare. It is advisory and does not determine breach, regulatory failure, indemnity position or clinical-safety status for any specific clinic. Final legal, data protection, clinical safety, regulatory, insurer and indemnity decisions remain with the clinic’s accountable officers, including the DPO, legal counsel and Clinical Safety Officer.